医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
REGN · REGENERON PHARMACEUTICALS, INC.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
REGENERON PHARMACEUTICALS, INC.（REGN）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $6.6M；高管董事有效买入 —、有效卖出 —。最近申报 2026-10-15。
买入 Bought—
卖出 Sold$6.6M
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-10-14 | MURPHY ANDREW J Co-Chief Scientific Officer | 卖出 Sell | 4,147 | $772.70 | $3.2M | SEC |
| 2026-09-02 | Guarini Kathryn Director | 卖出 Sell | 400 | $850.00 | $340K | SEC |
| 2026-09-02 | McCourt Marion EVP Commercial | 卖出 Sell | 2,346 | $853.56 | $2.0M | SEC |
| 2026-08-10 | Guarini Kathryn Director | 卖出 Sell | 400 | $800.00 | $320K | SEC |
| 2026-08-10 | Zoghbi Huda Y Director | 卖出 Sell | 800 | $800.00 | $640K | SEC |
| 2026-07-02 | RYAN ARTHUR F Director | 卖出 Sell | 200 | $650.15 | $130K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-10-14 | MURPHY ANDREW J Officer | 4,147 | $3.2M | 10b5-1 |
| 2026-09-03 | McCourt Marion Officer | 1,131 | $969K | 10b5-1 |
| 2026-09-02 | McCourt Marion Officer | 1,215 | $1.0M | 10b5-1 |
| 2026-09-02 | Guarini Kathryn Director | 400 | $340K | 10b5-1 |
| 2026-08-10 | Zoghbi Huda Y Director | 800 | $640K | 10b5-1 |
| 2026-08-10 | Guarini Kathryn Board member | 400 | $320K | 10b5-1 |
| 2026-07-02 | RYAN ARTHUR F Director | 400 | $250K | 10b5-1 |
内部人 Insiders
MURPHY ANDREW J、Guarini Kathryn、McCourt Marion、Zoghbi Huda Y、RYAN ARTHUR F